Kiniksa Pharmaceuticals

KNSA NASDAQ
Overview Stats Financials News

Price & Volume

Stats

See more
52W Range $13.37-$22.09
Market Cap $1.4B
Shares Short 3M

Financials

See more
Revenue (12 Mos) $301.7M
Revenue Growth (YoY) 65.2%
Gross Profit (12 Mos) $173.2M
Diluted EPS $0.13

About

CEO Mr. Sanj K. Patel
CFO Mr. Mark Ragosa C.F.A.
Address Clarendon House, Hamilton, Bermuda, HM 11
Sector Healthcare
Industry Biotechnology
Full-Time Employees 297